Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/11/2021 01/12/2021 01/13/2021 01/14/2021 01/15/2021 Date
110.84(c) 108.84(c) 112.15(c) 110.04(c) 111.3(c) Last
3 177 736 5 777 386 6 047 106 4 391 349 4 459 430 Volume
-0.69% -1.80% +3.04% -1.88% +1.15% Change
More quotes
Financials (USD)
Sales 2020 33 853 M - -
Net income 2020 4 415 M - -
Net Debt 2020 11 794 M - -
P/E ratio 2020 45,4x
Yield 2020 1,29%
Sales 2021 38 321 M - -
Net income 2021 5 807 M - -
Net Debt 2021 8 819 M - -
P/E ratio 2021 35,1x
Yield 2021 1,41%
Capitalization 191 B 191 B -
EV / Sales 2020 5,98x
EV / Sales 2021 5,21x
Nbr of Employees 107 000
Free-Float 88,9%
More Financials
Company
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicine. It offers products,... 
More about the company
Notations Surperformance© of Abbott Laboratories
Trading Rating : Investor Rating :
More Ratings
All news about ABBOTT LABORATORIES
01/15ABBOTT LABORATORIES : To launch the neurosphere mypath digital health app design..
AQ
01/14ABBOTT : to Launch the NeuroSphere™ myPath™ Digital Health App Desig..
PR
01/14ABBOTT LABORATORIES : Ex-dividend day for
FA
01/13ABBOTT LABORATORIES : Announces fulfillment of federal government purchase of 15..
AQ
01/12ABBOTT LABORATORIES : Fulfills US Government's Order of 150 Million BinaxNOW COV..
MT
01/12ABBOTT : Announces Fulfillment of Federal Government Purchase of 150 Million Bin..
PR
01/11ABBOTT LABORATORIES : Receives FDA 510(k) Clearance for Rapid Handheld Blood Tes..
MT
01/11ABBOTT : Receives FDA 510(k) Clearance for the First Rapid Handheld Blood Test f..
PR
01/06ABBOTT : Hosts Conference Call for Fourth-Quarter Earnings
PR
2020ABBOTT LABORATORIES : - as vaccines roll out, americans see covid-19 testing as ..
AQ
2020ABBOTT LABORATORIES : As Vaccines Roll Out, Americans See COVID-19 Testing as Im..
PR
2020ABBOTT LABORATORIES : To present at j.p. morgan healthcare conference
AQ
2020ROCHE : EU Signs $122 Million Deal for COVID-19 Rapid Antigen Tests From Abbott,..
MT
2020ABBOTT : to Present at J.P. Morgan Healthcare Conference
PR
2020ABBOTT LABORATORIES : Wins FDA Approval to Update Labeling on HeartMate 3 Heart ..
MT
More news
News in other languages on ABBOTT LABORATORIES
2020Des sorcières, des dragons et des pirates
2020AVIS D'ANALYSTES DU JOUR : ABB, Delta Plus, EDP, Galapagos, HelloFresh, Sika, Ve..
2020CORONAVIRUS : Mepha distribue en Suisse le test rapide d'Abbott
2020Generikafirma Mepha holt weiteren Covid-19-Schnelltest in die Schweiz
2020AVIS D'ANALYSTES DU JOUR : Adidas, Chargeurs, Daimler, EDF, Ipsen, L'Oréal, SAP,..
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 120,22 $
Last Close Price 111,30 $
Spread / Highest target 21,3%
Spread / Average Target 8,02%
Spread / Lowest Target -26,3%
EPS Revisions
Managers and Directors
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES1.65%190 701
MEDTRONIC PLC-0.28%157 229
BECTON, DICKINSON AND COMPANY4.60%76 127
HOYA CORPORATION-2.24%50 041
ALIGN TECHNOLOGY, INC.6.15%44 726
BAXTER INTERNATIONAL INC.-0.25%40 886